tirzepatide new england journal of medicine Once Weekly in Children and Adolescents with Type 2 Diabetes (SURPASS-Peds). The Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 In the two SURMOUNT-OSA trials,

The pathogenic mechanism of OA include damage to periarticular cartilage and subchondral bone, synovitis, and the critical involvement of chondrocytes in this process

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

- Served as an army pathologist in Vietnam, which inspired his transition from pathology to internal medicine and eventually oncology

We dont promise overnight miracles

It is still in clinical trials but has generated such interest that some users are already sourcing it illegally online before approval

In the SUSTAIN-6 trial, semaglutide was associated with a significant increased risk of diabetic retinopathy complications, including vitreous hemorrhage, blindness, or conditions requiring treatment with an intravitreal agent or photocoagulation (HR 1.76, 95% CI 1.112.78) [27]